Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Brain Research|June 10, 2011
Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in miceIngrid Tulloch, Nane Ghazaryan, Ina Mexhitaj, et al.
Brain Research|March 26, 2013
The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of miceLauriaselle Afanador, Ina Mexhitaj, Carolyn Diaz, et al.
Plos One|August 23, 2014
A complex role of herpes viruses in the disease process of multiple sclerosisSimone C Wuest, Ina Mexhitaj, Noo Ri Chai, et al.
Journal of Immunological Methods|August 30, 2022
Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trialsIna Mexhitaj, Noha Lim, Jose I Fernandez-Velasco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2014
Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseasesSungpil Han, Yen Chih Lin, Tianxia Wu, et al.
Brain : a Journal of Neurology|February 14, 2019
Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosisIna Mexhitaj, Mukanthu H Nyirenda, Rui Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2021
Pro-inflammatory adiponectin in pediatric-onset multiple sclerosisMukanthu H Nyirenda, Giulia Fadda, Luke M Healy, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Pediatric cerebrospinal fluid immune profiling distinguishes pediatric-onset multiple sclerosis from other pediatric-onset acute neurological disordersDiego A Espinoza, Tobias Zrzavy, Gautier Breville, et al.
Ebiomedicine|January 6, 2026
Paediatric cerebrospinal fluid immune profiling distinguishes paediatric-onset multiple sclerosis from other paediatric-onset acute neurological disordersDiego A Espinoza, Tobias Zrzavy, Gautier Breville, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Pageof 2